Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABT

Abbott

$68.18

-1.97 (-2.81%)

09:03
10/19/18
10/19
09:03
10/19/18
09:03
Hot Stocks
Abbott s HeartMate 3 heart pump approved by FDA for advanced heart failure »

Abbott's HeartMate 3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$68.24

-0.81 (-1.17%)

, MDT

Medtronic

$95.95

-1.31 (-1.35%)

08:32
10/19/18
10/19
08:32
10/19/18
08:32
Hot Stocks
NuVasive names J. Christopher Barry to succeed Gregory Lucier as CEO »

NuVasive (NUVA) announced…

NUVA

NuVasive

$68.24

-0.81 (-1.17%)

MDT

Medtronic

$95.95

-1.31 (-1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 27

    Nov

NVRO

Nevro

$53.93

-1.25 (-2.27%)

, DXCM

DexCom

$132.89

0.21 (0.16%)

05:10
10/19/18
10/19
05:10
10/19/18
05:10
Downgrade
Nevro, DexCom, Boston Scientific rating change at Goldman Sachs »

Nevro downgraded to Sell…

NVRO

Nevro

$53.93

-1.25 (-2.27%)

DXCM

DexCom

$132.89

0.21 (0.16%)

BSX

Boston Scientific

$37.52

-0.47 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 05

    Nov

  • 06

    Nov

DXCM

DexCom

$132.89

0.21 (0.16%)

05:07
10/19/18
10/19
05:07
10/19/18
05:07
Upgrade
DexCom rating change at Goldman Sachs »

DexCom upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

Yesterday
ABT

Abbott

$70.15

-0.79 (-1.11%)

08:11
10/18/18
10/18
08:11
10/18/18
08:11
Recommendations
Abbott analyst commentary at Leerink »

Abbott sales growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$70.15

-0.79 (-1.11%)

07:10
10/18/18
10/18
07:10
10/18/18
07:10
Recommendations
Abbott analyst commentary at Stifel »

Abbott franchises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Wednesday
ABT

Abbott

$70.94

2.22 (3.23%)

09:33
10/17/18
10/17
09:33
10/17/18
09:33
Hot Stocks
Abbott says it sees great returns from Libre »

Says the street does not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ABT

Abbott

$70.94

2.22 (3.23%)

09:16
10/17/18
10/17
09:16
10/17/18
09:16
Earnings
Breaking Earnings news story on Abbott »

Abbott sees FY18 sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ABT

Abbott

$70.94

2.22 (3.23%)

09:16
10/17/18
10/17
09:16
10/17/18
09:16
Earnings
Breaking Earnings news story on Abbott »

Abbott sees Q4 sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ABT

Abbott

$70.94

2.22 (3.23%)

07:50
10/17/18
10/17
07:50
10/17/18
07:50
Hot Stocks
Abbott CEO say expects to achieve 'upper end of our initial full-year guidance' »

"We achieved another…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.